Latest Glioma Stories

(Ivanhoe Newswire) -- The more allergies on has, the lower the risk of developing low- and high-grade glioma, according to this study.Researchers from the University of Illinois at Chicago, used self-reported data on medically diagnosed allergies and antihistamine use for 419 patients with glioma and 612 cancer-free patients from Duke University and NorthShore University HealthSystem. Controls had no history of brain tumors or any cancers, and did not have a history of neurodegenerative...

The more allergies one has, the lower the risk of developing low- and high-grade glioma, according to data published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.Researchers from the University of Illinois at Chicago, used self-reported data on medically diagnosed allergies and antihistamine use for 419 patents with glioma and 612 cancer-free patients from Duke University and NorthShore University HealthSystem. Controls had no...

Rice bioengineers, Baylor College of Medicine and Texas Children's physician-scientists zap tumors with light-activated nanoparticlesRice University bioengineers and physician-scientists at Baylor College of Medicine and Texas Children's Hospital have successfully destroyed tumors of human brain cancer cells in the first animal tests of a minimally invasive treatment that zaps glioma tumors with heat. The tests involved nanoshells, light-activated nanoparticles that are designed to destroy...

CLEARWATER, Fla., Jan. 25, 2011 /PRNewswire/ -- Cutting edge, patient-specific vaccine treatments like DCVax® provide for a longer life expectancy along with a better quality of life for brain cancer patients, an improvement over current conventional brain tumor treatments. "The vaccine that I received has extended the median survival of Grade IV brain cancer (GBM) from 14.6 months, with conventional treatment, to over 36 months," stated Bob Gibbs, a 7 year brain cancer survivor, who has...

Missing studies could be conducted within a reasonable amount of time through international cooperationMalignant gliomas are fast-growing brain tumors with poor prospects of recovery depending on disease stage. Experts hope that the examination of patients by means of positron emission tomography (PET) is more helpful in the choice of the right treatment than other procedures. In a final report the German Institute for Quality and Efficiency in Health Care (IQWiG) has now investigated the...

Scientists have identified the type of cell that is at the origin of brain tumors known as oligodendrogliomas, which are a type of glioma "“ a category that defines the most common type of malignant brain tumor.In a paper published in the December 2010 issue of the journal Cancer Cell, investigators found that the tumor originates in and spreads through cells known as glial progenitor cells "“ cells that are often referred to as "daughter" cells of stem cells. The work comes at a time...

New research shows that loss of a gene called NFKBIA promotes the growth of glioblastoma multiforme, the most common and deadly form of brain cancer, and suggests that therapies that stabilize this gene may improve survival for certain glioblastoma patients.The study was published recently in the New England Journal of Medicine."We show that NFKBIA status may be an independent predictor of survival in certain patients with glioblastoma," says senior coauthor Dr. Arnab Chakravarti, chair and...

(Ivanhoe Newswire) "“ New insight into the biology of many kinds of less aggressive but lethal brain tumors, or gliomas, opens up a wide variety of possibilities for new therapies, according to this study.The researchers describe how genetic mutation leads to an abnormal metabolic process in the tumors that could be targeted by drug makers."What this tells you is that there are some forms of tumors with a fundamentally altered process," Karl Kelsey, a professor of pathology and...

A new property of a gene known for its involvement in tumor cell development, growth, and metastasis has been discovered by National Foundation for Cancer Research scientist Paul B. Fisher, M.Ph., Ph.D. and his team at Virginia Commonwealth University. The researchers discovered that the AEG-1 gene protects cancer cells from destruction by chemotherapy, thus enabling aggressive cancers to withstand treatment. This property of the AEG-1 gene was previously unknown. Bethesda, MD (PRWEB)...

A newly published insight into the biology of many kinds of less-aggressive but still lethal brain tumors, or gliomas, opens up a wide array of possibilities for new therapies, according to scientists at Brown University and the University of California, San Francisco (UCSF). In paper published online Dec. 15 in the Journal of the National Cancer Institute, they describe how a genetic mutation leads to an abnormal metabolic process in the tumors that could be targeted by drug...